“Dr. Arbet-Engels is a highly respected and experienced global pharmaceutical executive with keen business acumen honed over more than 20 years serving in complex organizational settings,” said Leslie Loveless, Slone Partners CEO. “We are very pleased to have been able to place him at X4 where we believe his extraordinary drive, passion, and vision – and his proven track record of success – will make a wonderful addition to the company’s leadership team.”
“It was truly a pleasure collaborating with Slone Partners on the placement of Christophe as our new Chief Medical Officer,” said Paula Ragan, Ph.D., President and Chief Executive Officer of X4 Pharmaceuticals, “We very much value our relationship with the Slone team and consider them a valuable ongoing resource to X4 given their deep understanding of and high quality connections within the life science industry.”
ABOUT SLONE PARTNERS
Slone Partners delivers the leaders who build amazing and diverse life sciences and healthcare organizations – People Are Our Science®. Founded in 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established biotech, diagnostics, research tools, healthcare, precision medicine, medical device, and laboratory services companies. With national and global clients, Slone Partners uniquely and precisely provides an array of executive search and advisory services, including diversity, equity, and inclusion strategy, to innovative life sciences and healthcare companies. To learn more about Slone Partners’ value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.
Media Contact
Doug Gavel, Doug Gavel Communications, (617) 429-4417, [email protected], www.douggavel.com
SOURCE Slone Partners
